SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 393.24+1.1%Dec 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (184553)2/28/2022 8:49:37 AM
From: Julius Wong   of 218477
 
Arbutus (ABUS) rallied more than 10% in pre-market action after it filed a lawsuit against Moderna (MRNA), alleging patent violations related to MRNA's COVID vaccine. The lawsuit, which includes Genevant Sciences as a plaintiff, does not seek to block the manufacture and distribution of the product. Rather, the companies are looking to collect damages.

seekingalpha.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext